Related Experiment Video

Updated: Jun 22, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Is tamoxifen a genotoxic carcinogen in women?

Karen Brown1

  • 1Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, UK. kb20@le.ac.uk

Mutagenesis
|June 10, 2009
PubMed

Insights

Tamoxifen, used for breast cancer, increases endometrial cancer risk. Its genotoxic mechanisms in rats involve DNA adducts, but human relevance requires further research for risk-benefit assessment.

Area of Science:

  • Oncology
  • Pharmacology
  • Toxicology

Background:

  • Tamoxifen is a widely used anti-oestrogen for breast cancer treatment and prevention.
  • Tamoxifen is associated with an increased incidence of endometrial cancer in women.
  • Understanding tamoxifen's carcinogenic mechanisms is crucial for assessing its risk-benefit profile, especially in chemoprevention.

Purpose of the Study:

  • To review the clinical rationale for using tamoxifen as a chemopreventive agent.
  • To describe the genotoxic mechanisms of tamoxifen-induced tumors in rat liver.
  • To evaluate the potential relevance of these mechanisms to human endometrial cancer.

Main Methods:

  • Review of existing clinical data on tamoxifen's chemopreventive use.
  • Analysis of studies investigating tamoxifen metabolism and DNA adduct formation in rat liver.
  • Discussion of current data on tamoxifen-DNA adducts in human tissues and cellular responses.

Main Results:

  • Tamoxifen is metabolically activated in rat liver via alpha-hydroxylation and sulphate conjugation.
  • This activation produces a reactive species that forms DNA adducts, primarily at the N(2)-position of guanine, leading to pro-mutagenic lesions.
  • The direct contribution of these adducts to human endometrial cancer remains to be fully elucidated.

Conclusions:

  • Tamoxifen's genotoxic activation pathway in rats is well-characterized.
  • Further research is needed to determine if similar mechanisms operate in humans and contribute to endometrial carcinogenesis.
  • Clarifying the human relevance of tamoxifen-induced DNA adducts is essential for accurate risk assessment.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry08:59

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry

Published on: July 17, 2017

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...